← Leaderboards
Cecile Feldman
Rbhs-School Of Dental Medicine
$11,278,781
Attributed
$11,278,781
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.4M · FY2019–23$5M$3.8M$2.5M$1.3M$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$11,278,781 · 2
By mechanism
UH3$10,650,274 · 1
UG3$628,507 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Acetaminophen”
- Prashant Mishra · Ut Southwestern Medical Center$2,999,512
- Lisa Doan · New York University School Of Medicine$2,885,464
- Andrew Wang · Yale University$2,853,345
- Daniel J. Wallace · Upstate Medical University$2,360,490
- Chani Traube · Children'S Research Institute$2,288,784
- Richard Holubkov · Johns Hopkins University$2,288,784
Research focus
AcetaminophenAcute PainAcute Pain ManagementAcuteAdolescent And Young AdultAdverse EffectsAdverse EventAdverse ReactionsAnalgesicsAddictionBehaviorCapsuleCaringClient SatisfactionClinicClinical Decision-MakingClinical ProtocolsConstipationDaily FunctioningDatabasesDecision MakingDentalDental CareDentists
Grant awards (5)
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain$1,130,794
UH3 · FY2023 · DE · contact PI
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain$2,960,004
UH3 · FY2022 · DE · contact PI
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain$3,127,499
UH3 · FY2021 · DE · contact PI
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain$3,431,977
UH3 · FY2020 · DE · contact PI
Opiod Analgesic Reduction Study (OARS): Managing Acute Post-Operative Surgical Pain$628,507
UG3 · FY2019 · DE · contact PI